This product is a recombinant human antibody scFv fragment that recognizes colony stimulating factor 1 receptor, a type III tyrosine kinase receptor known to be involved in various cancers and inflammatory diseases. The epitope of the predicted antibody primarily encompasses the D1 domain located in the N-terminal extracellular region of CD115, along with certain residues from the D2 domain. The single-chain fragment variable (scFv) is a genetically engineered antibody with significant versatility for various applications in research, diagnostics, and clinical settings. Its molecular weight is approximately 28 kDa.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-178CL | Afuco™ Anti-CSF1R Recombinant Antibody (AFC-178CL), ADCC Enhanced | ELISA, WB | Human IgG1 |
AFC-TAB-H23 | Afuco™ Anti-CSF1R ADCC Recombinant Antibody (Emactuzumab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut | ADCC enhanced antibody |
AFC-TAB-011ML | Afuco™ Anti-CSF1R ADCC Recombinant Antibody (Cabiralizumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
There are currently no Customer reviews or questions for HPAB-0153-FY-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.